Spero Therapeutics, Inc.SPRONASDAQ
Loading
Net Margin Over TimeExpanding
Percentile Rank70
Studio
Year-over-Year Change

Net income as a percentage of revenue

Percentile
P70
Within normal range
vs 2Y Ago
-5.6x
Contraction
Streak
1 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM-122.56%+14.2%
2024-142.91%-750.3%
202321.98%+123.0%
2022-95.55%+96.7%
2021-2923.65%-248.5%
2020-839.01%-149.9%
2019-335.73%+68.0%
2018-1050.48%+54.9%
2017-2329.31%+69.4%
2016-7609.25%-